ABBOTT INDIA LIMITED

The global prostate cancer diagnostics market is projected to grow from $5.8B in 2023 to $13.7B by 2030, driven by aging populations, tech advancements, and precision medicine. The preliminary test segment is expected to reach $10B by 2030.

Global Nanopharmaceuticals Market expected to grow from USD 7.5 Billion in 2023 to USD 259.2 Billion by 2032, driven by advantages like enhanced bioavailability, targeted delivery, and reduced side effects. North America leads with USD 25.3 Billion in 2023. Nanopharmaceuticals revolutionize drug delivery, addressing complex diseases and overcoming traditional therapy limitations.

Nearly 20,000 Big Ten students, alumni, and fans donated blood, saving up to 60,000 lives in the Abbott-Big Ten blood donation competition. The University of Nebraska-Lincoln won, receiving $1 million from Abbott for student and community health. The competition aims to address the largest blood shortage in a generation and create new lifelong donors.

The Heart Failure POC & LOC Devices Market was valued at USD 95.94 million in 2023 and is expected to reach USD 401.91 million by 2032, growing at a CAGR of 17.26% over the forecast period 2024-2032. Key growth drivers include rising demand for early detection, AI integration, and decentralized care. Proteomic testing and microfluidics technology dominate the market segments.

The global precision medicine market was valued at USD 102.17 billion in 2024, expected to reach USD 470.53 billion by 2034, growing at a CAGR of 16.5%. Precision medicine involves personalized treatments based on genetic, environmental, and behavioral profiles. Key technologies include next-generation sequencing and bioinformatics. The U.S. leads with the NIH's 'All of Us Research Program' and collaborations like AstraZeneca's cancer research. AI tools like Tempus and Foundation Medicine enhance genomic analysis. Potential benefits include improved patient privacy, new data tools, and better FDA oversight. North America dominates the market, with Asia-Pacific expected to grow fastest due to strategic collaborations and government standards.

A journalist tries a continuous glucose monitor (CGM) marketed as a wellness tool, finding it influences food choices and diet, unintentionally adopting a keto approach. Experts warn CGMs should be used correctly, as they are life-changing for insulin-dependent diabetics. Dexcom and Abbott now offer CGMs without prescriptions, aiming to provide health insights. The journalist's experience shows the CGM can affect eating habits and behavior, but scientific consensus on their value for non-diabetics is lacking.

Girardi notes IVD market growth varies by segment; pathology and digital pathology to grow faster due to staining and digital tech advancements. Roche leads the IVD market, with Mindray making significant inroads in APAC and Latin America. Regional growth rates differ, with North America at 2% CAGR, and Latin America and Asia Pacific at around 5%. Ravishankar highlights rapid diagnostics' role in improving patient outcomes, emphasizing access to testing and precision care. US decentralized testing market growth expected at up to 9%, dependent on reimbursement, patient flow, and tech adoption.

FDA approves Medtronic's InPen app, enabling launch of Smart MDI system with Simplera CGM, aiming to enhance type 1 diabetes management through precise insulin dosing and real-time data integration.

The global Next Generation Cancer Diagnostics market is projected to grow from $16.6B in 2023 to $64.6B by 2030, driven by increasing cancer prevalence, personalized medicine advancements, and regulatory approvals. Key technologies include liquid biopsy and NGS, with applications in screening, diagnostics, and treatment monitoring.

The global biopharmaceuticals market is projected to reach USD 566 billion by 2032, driven by innovations in treating previously untreatable diseases. North America led in 2022 with a 43% share. Key players like Pfizer and InflaRx are advancing therapies, but challenges include high costs and regulatory complexities. The industry is also focusing on sustainability and digital transformation.